Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Genitourinary Cancer
Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer
NCT04936230
Genitourinary Cancers – Kidney / Bladder / Urothelial / Testicular
Closed
Himanshu Nagar
Cancer Control
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
NCT03578081
Other Cancer
Closed
Rudolph Navari, MD, PhD, FACP
Leukemia
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182
Leukemia & Myelodysplastic Syndromes (MDS)
Closed
Janet Rowley, MD
Gastrointestinal Cancer
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
NCT00052910
Gastrointestinal Cancers – Pancreatic / Gastric / Esophageal / Liver / Biliary
Closed
Charles Fuchs, MD, MPH
Breast Cancer
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
NCT00265759
Breast Cancer
Closed
Matthew J. Ellis, MD, PhD, FRCP
Genitourinary Cancer
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
NCT04455750
Prostate Cancer
Open
Arpit Rao, MD
Respiratory Cancer
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
NCT00042770
Other Cancer
Closed
Todd Demmy, MD
Myeloma
Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT03702725
Multiple Myeloma & Plasma Cell Disorders
Closed
Yvonne A. Efebera, MD; Jacob P. Laubach, MD
Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00798603
Lung Cancer & Mesothelioma
Closed
Grace K. Dy, MD
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
NCT00301821
Lymphoma
Closed
Ivana Micallef, MD

Research in Action

See how Alliance trials are advancing treatment

Alliance News